Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Daehan Nupharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	78,317	92,212	96,422	127,019	119,861	152,985
Market Cap Growth	-20.96%	-4.37%	-24.09%	5.97%	-21.65%	-13.49%
Enterprise Value	152,484	155,749	114,707	125,867	131,114	172,368
Last Close Price	5580.00	6570.00	6766.22	8786.32	8199.26	10348.04

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	5.00	6.04	6.23	10.13	4.93	9.75
PS Ratio	0.38	0.46	0.48	0.62	0.61	0.92
PB Ratio	0.57	0.66	0.77	1.16	1.16	1.86
P/TBV Ratio	0.57	0.67	0.78	1.17	1.17	1.87
P/FCF Ratio	-	-	-	44.89	11.08	25.68
P/OCF Ratio	40.05	18.22	5.09	10.11	8.41	9.23

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.74	0.77	0.57	0.62	0.66	1.03
EV/EBITDA Ratio	10.26	9.72	5.04	5.63	4.21	5.80
EV/EBIT Ratio	14.55	13.28	6.15	6.67	4.69	6.53
EV/FCF Ratio	-	-	-	44.48	12.12	28.93

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.78	0.71	0.47	0.34	0.36	0.45
Debt / EBITDA Ratio	7.17	6.17	2.61	1.64	1.18	1.24
Debt / FCF Ratio	-	-	-	12.93	3.39	6.20
Net Debt / Equity Ratio	0.54	0.47	0.18	0.12	0.07	0.18
Net Debt / EBITDA Ratio	4.95	4.12	0.96	0.57	0.23	0.49
Net Debt / FCF Ratio	-1.78	-1.46	-1.56	4.53	0.67	2.45
Asset Turnover	0.81	0.82	1.01	1.18	1.21	1.15
Inventory Turnover	2.81	2.84	3.04	3.54	4.30	4.83
Quick Ratio	0.98	0.97	1.06	1.01	1.11	1.16
Current Ratio	1.57	1.55	1.61	1.60	1.75	1.69
Return on Equity (ROE)	11.85%	11.50%	13.18%	11.81%	26.23%	22.15%
Return on Assets (ROA)	2.60%	2.98%	5.86%	6.81%	10.68%	11.36%
Return on Invested Capital (ROIC)	5.08%	6.64%	11.66%	9.84%	19.00%	20.15%
Return on Capital Employed (ROCE)	5.30%	5.90%	12.50%	16.40%	25.20%	23.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	20.02%	16.55%	16.04%	9.87%	20.29%	10.26%
FCF Yield	-53.09%	-48.99%	-14.61%	2.23%	9.03%	3.90%
Payout Ratio	8.95%	9.20%	9.07%	11.19%	4.62%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error